References
- 1. Carroll GJ, Bayliss CE. Treatment of arthropathy of familial hypercholesterolaemia. Ann Rheum Dis. 1983;42(2):206-9.10.1136/ard.42.2.2066847268
- 2. Mathon G, Gagne C, Brun D, Lupien PJ, Moorjani S. Articular manifestations of familial hypercholesterolaemia. Ann Rheum Dis. 1985;44(9):599-602.403788510.1136/ard.44.9.599
- 3. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986;232 (4746):34-47.
- 4. Braun-Falco O, Plewig G, Wolff HH, Winkelmann RK. Skin disorders caused by disturbances of lipid metabolism. In: Braun-Falco O, Plewig G, Wolff HH, Winkelmann RK. Dermatology. Berlin: Springer; 1991. p. 849-60.10.1007/978-3-662-00181-3_37
- 5. Civeira F; International Panel on Management of Familial Hypercholesterolemia. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia. Atherosclerosis. 2004;173(1):55-68.
- 6. Linton MF, Fazio S. Class A scavenger receptors, macrophages and atherosclerosis. Curr Opin Lipidol. 2001;12(5):489-95.10.1097/00041433-200110000-00003
- 7. Kruth HS. Lipid deposition in human tendon xanthoma.Am J Pathol. 1985;121(2):311-5.
- 8. Tall AR, Small DM, Lees RS. Interaction of collagen with the lipids of tendon xanthomata. J Clin Invest. 1978;62(4):836-46.
- 9. Ferrieres J, Lambert J, Lussier-Cacan S, Davignon J. Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation. Circulation. 1995;92(3):290-5.10.1161/01.CIR.92.3.290
- 10. Artieda M, Cenarro A, Junquera C, Lasierra P, Martínez-Lorenzo MJ, Pocoví M, et al. Tendon xanthomas in familial hypercholesterolemia are associated with a differential inflammatory response of macrophages to oxidized LDL. FEBS Lett. 2005;579(20):4503-12.
- 11. Zak A, Zeman M, Slaby A, Vecka M. Xanthomas: clinical and pathophysiological relations. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014;158(2):181-8.
- 12. Chakraborty PP, Mukhopadhyay S, Achar A, Pal M, Mondal PC. Migratory polyarthritis in familial hypercholesterolemia (type IIa hyperlipoproteinemia). Indian J Pediatr. 2010;77(3):329-31.
- 13. Myasoedova E, Crowson CS, Kremers HM, Roger VL, Fitz-Gibbon PD, Therneau TM, et al. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis. 2011;70(3):482-7.10.1136/ard.2010.135871
- 14. Drechsler M, Megens RT, van Zandvoort M, Weber C, Soehnlein O. Hyperlipidemia triggered neutrophilia promotes early atherosclerosis. Circulation. 2010;122 (18):1837-45.